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Abstract  
Preterm birth is a serious and costly health problem, which affects nearly 1 in 8 births in 
the United States.  Intravenous, or parenteral, nutrition is often required in very preterm infants 
(<33 weeks gestational age), whose digestive tracts are too immature to receive enteral nutrition.  
Unfortunately, current parenteral feeding methods are also associated with metabolic 
complications including hyperglycemia, which is a primary factor in postnatal morbidity and 
mortality.  Peripheral insulin resistance is a key factor contributing to hyperglycemia in preterm 
neonates receiving parenteral nutrition, but the relationship between preterm birth and 
mechanisms of insulin-stimulated glucose disposal are not well understood.  We hypothesized 
that compared to neonates born full term, preterm neonates possess a diminished capacity for 
glucose uptake and usage in skeletal muscle.  To test this, mRNA transcript amounts were 
measured in skeletal muscle tissue of preterm and term pigs (delivered on days 106 and 114 of 
gestation, respectively).  Tissue was collected after 6 d of parenteral feeding and transcript 
amounts for enzymes involved in glucose transport (GLUT1 and GLUT4), glycogen synthesis 
(glycogen synthase), glycogen degradation (glycogen phosphorylase), and fatty acid oxidation 
(carnitine palmitoyltransferase I [CPT I]) were determined.  Preterm pigs displayed increased (P 
< 0.05) expression of GLUT4, CPT I, and glycogen phosphorylase transcripts relative to term 
pigs.  This suggests that mechanisms for glucose uptake in the preterm neonate are immaturely 
developed and that muscle cells derive energy more heavily from fatty acids and glycogen stored 
prenatally as alternatives to circulating glucose.  Further investigation of the activity and protein 
quantities of these enzymes is necessary to validate these conclusions.   
 
  
Introduction 
In the United States, preterm birth (<37 weeks gestation) affects approximately 1 in 8 
births (Behrman & Butler, 2007) and in 2002, 65% of all infant deaths occurred in infants born 
preterm (Mathews et al., 2004).  The incidence of preterm birth has increased over 30% since 
1981, and in 2005 alone, the estimated cost of medical services related to preterm birth was 
$16.9 billion (Behrman & Butler, 2007). In spite of this elevated incidence and cost, little is 
known about the consequences that preterm birth and its associated medical treatments have 
upon metabolic capacity for nutrient utilization (Green et al., 2005).   
Parenteral (intravenous) nutrition is often required in very preterm infants (< 33 weeks 
gestational age), whose digestive tracts are too immature to receive enteral nutrition.  
Unfortunately, parenteral nutrition may also predispose neonates to hyperglycemia, which occurs 
in up to 68% of preterm infants receiving intravenous glucose, but only 5% of term neonates 
(Mericq, 2006).  The incidence and severity of hyperglycemia vary widely based on the infant’s 
degree of developmental immaturity, but it is clear that any level of hyperglycemia is associated 
with an increased risk of morbidity and mortality among premature infants (Hays et al., 2006).    
In recent years, researchers have identified a number of factors that are believed to 
contribute to the development and maintenance of hyperglycemia in preterm infants receiving 
parenteral nutrition.  These include defective pancreatic insulin secretion, hepatic insensitivity to 
glucose, decreased abundance of insulin-sensitive tissues, and partial insulin resistance in both 
hepatic and peripheral tissues (Mitanchez, 2007).  It is also now clear that in the preterm neonate 
blood glucose homeostasis (or the lack thereof) is primarily determined by two important 
metabolic processes: hepatic gluconeogenesis and insulin-stimulated glucose uptake by 
peripheral tissues (Rozance, 2011).  Much of the clinical research has focused upon the first of 
these processes, but persistent hepatic gluconeogenesis has been recognized as a normal 
characteristic of early postnatal development for the last three decades (Cowett et al., 1983).   
Accordingly, a wide range of experimental treatments have all proven ineffective in slowing 
hepatic gluconeogenesis in the preterm neonate (Chacko et al., 2011; Chacko & Sunehag, 2010; 
Farrag et al., 1997; Sunehag, 2003; Sunehag et al. 1993; Sunehag et al. 1994).    
Alternatively, the results of research employing the euglycemic hyperinsulinemic clamp 
suggest that insulin-stimulated glucose disposal may be a more responsive target for clinical 
management of glucose homeostasis (Farrag et al., 1997).  Indeed, a recent study found that early 
treatment with intravenous insulin infusion successfully reduced the incidence of hyperglycemia 
in a relatively large sample of premature infants (Beardsall et al., 2008).   Surprisingly, very little 
research has investigated the relationship between preterm birth and the metabolic pathways 
underlying insulin-stimulated glucose uptake and utilization.   
In healthy individuals, skeletal muscle is the primary site for insulin-stimulated glucose 
disposal, and within muscle tissue; transport across the cell membrane is the rate-limiting step 
for glucose metabolism (Shepherd & Kahn, 1999).   This process is predominantly dependent 
upon two transport proteins, which change in concentration at birth.  The insulin independent 
GLUT1 is the predominant transporter during fetal development.  At birth, the expression of 
GLUT1 diminishes quickly and is replaced by the insulin-sensitive transporter, GLUT4.  By the 
end of the first year of life, expression of GLUT1 is undetectable, and GLUT4 is the only 
glucose transporter observed in human skeletal muscle (Gaster et al., 2000).  In the developing 
fetus, GLUT4 has been observed in muscle tissue as early as 18 weeks gestational age, but it 
does not exhibit an adult-like pattern of subcellular localization until after birth (Gaster et al., 
2000).  Additionally, insulin does not become active in the developing fetus until the onset of 
corticosteroid action late in the second trimester (Mena et al., 2001).  In cases of preterm birth, 
this developmental timeline suggests that muscle tissue may be inadequately prepared for the 
transition to primarily insulin-stimulated glucose uptake, but to our knowledge, this relationship 
has not yet been explored in the research literature.   
Similarly, glycogen synthesis does not begin until the second trimester of fetal 
development, and gradually increases until birth.  Accordingly, minimal prenatal glycogen 
storage is recognized as a primary cause of hypoglycemia in preterm infants that do not receive 
early parenteral glucose (Mitanchez, 2007). To our knowledge however, no research has 
examined whether preterm infants also have a diminished capacity to synthesize glycogen 
relative to infants born full term.  As glycogen synthesis is a major destination for glucose 
disposal following transport into peripheral tissues (Shulman et al., 1990; Woerle et al., 2003), 
an impairment of this nature could have significant implications for the ability of preterm 
neonates to maintain glucose homeostasis.   
The current study sought to assess differences in the capacity for glucose uptake and 
utilization in the skeletal muscle of preterm and full term pigs receiving total parenteral nutrition 
(TPN).  mRNA transcript abundance was measured for enzymes involved in glucose transport 
(GLUT1 and GLUT4), glycogen synthesis (glycogen synthase), glycogen degradation (glycogen 
phosphorylase), and fatty acid oxidation (carnitine palmitoyltransferase I [CPT I]).   It was 
hypothesized that relative to full term pigs, preterm pigs would exhibit a diminished capacity for 
glycogen synthesis and insulin-stimulated glucose uptake.   These deficiencies may also 
influence the processes of glycogen degradation and fatty acid oxidation in muscle tissue, as 
cells may be required to derive a greater proportion of energy from sources other than circulating 
glucose.   
Materials and Methods 
 Tissue Samples: All procedures were performed using frozen porcine skeletal muscle 
tissue samples, collected in a previous study (Campbell et al., 2009).  In brief, pigs were 
delivered by cesarean section at 106d (preterm; n=5) or 114d (full term; n=6) of gestation and 
fed TPN for six days before tissue collection.  TPN was formulated to meet all nutrient 
requirements and infused at rates required to promote moderate weight gain (Table 1).  
  
RNA Isolation:  Total RNA was isolated using guanidine isothiocyanate and phenol-based 
Trizol reagent (Invitrogen). RNA integrity was verified by agarose gel electrophoresis with 
ethidium bromide staining.  Quantity and purity were assessed using spectrophotometric analysis 
(NanoDrop 1000; Thermo Fisher Scientific) of A260 and the A260 : A280 ratio, respectively.  
Primer Development: Intron-spanning primers for GLUT1 (forward: 
CAGTATGTGGAGCAACTGTGC and reverse: CTTTGGTCTCGGGAACTTTG), GLUT4 
(forward: TTTCCAGTATGTTGCGGATG and reverse: CGGGTTTCAGGCACTTTTAG), 
glycogen synthase (forward: GCTACACGCCAGCTGAATG and reverse: 
Table 1.  Nutrient Content of TPN Solutions
1
 
Ingredients,    
% 
PUFA 
emulsion
2
 
Liposyn II, 
20% 
Aminosyn, 
8.5% 
Dextrose MVI-
Pediatric 
MTE-4 Calcium 
gluconate 
Preterm 0.35 15.2 53 14.4 0.5 0.01 0.075 
Full term  0.35 15.2 62.5 20.0 0.5 0.01 0.075 
1
Nutrient contents formulated according to Sangild et al. (2002)  and Wykes et al. (1993)  
2
PUFA emulsion contained 12.75% ARASCO, 7.25% DHA-S, 2.5% glycerol, 1.2% egg lecithin, and 0.3% 
sodium oleate 
GAGGGGTCTGCGATGTGTT), glycogen phosphorylase (forward: 
CCTGTACAAGAACCCGAGAGA and reverse: CCTGGCATACTGGGCAAT), muscle CPT I 
(forward: TCAAGCCTGTGATGGCTCTA and reverse: CTGCAGTGTGTCTGTGTCCTT), 
and cyclophilin A (forward: ATGTGCCAGGGTGGTGAC and reverse: 
AGGACCCGTATGCTTCAGG) were designed from published GenBank pig-specific sequences 
(Accession numbers GLUT1: EU012358.1, GLUT4: EU590115.1, glycogen synthase: 
GQ845034.1, glycogen phosphorylase: DQ508264.2, muscle CPT1: AY642381.1, and 
cyclophilin A: AY008846.1) using Primer3 v 0.4.0 software.  Optimal annealing temperature 
was determined experimentally for each primer set (60.5° C for GLUT4 and glycogen synthase; 
59.6° C for GLUT1, glycogen phosphorylase, and CPT I), and similarity of amplification 
efficiency for cyclophilin A and each target gene was validated.     
Real Time RT-PCR: Isolated RNA was reverse transcribed using Omniscript RT 
(Quiagen) and a mixture of random hexamer and oligoDT primers. Each reverse transcription 
reaction contained 1.5 µg of total RNA within a final reaction volume of 20 µL.  Real Time PCR 
was conducted using the Applied Biosystems 7500 Real-time PCR system (Applied Biosystems) 
and SYBR® Green (Quiagen) fluorescence was used for detection of cDNA. 1% uracil-N-
glycosylase (UNG) was included in the PCR reaction mixture to eliminate any carryover 
contamination.  After initial incubations at 60° C for 5 min followed by 95° C for 15 min, 
cycling parameters were 15 s at 94° C, 30 s at gene specific primer annealing temperature, and 
35 sec at 72° C for 40 cycles.  Fluorescence data was collected at the end of the elongation cycle 
and a melting curve was programmed and examined for detection of non-specific amplification 
products.  Samples were assayed in triplicate and negative (minus template and minus RT) 
controls were included in each assay.  Final reaction volume was 25 μL containing forward and 
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Figure 1 GLUT4 and GLUT1 relative transcript abundance in preterm (n=5)    
and full term (n=6) pigs.  Bars represent mean ± SEM.  *Different from the 
corresponding full term, P < .05. 
Full term 
Preterm 
* 
reverse primers (Sigma-Aldrich Custom Primers), each at a concentration of 0.3 μmol/L, and 1.0 
µL of cDNA template transferred directly from the products of the RT reactions.   
Statistical Analysis: Relative transcript amounts were calculated using the  2
-∆∆C
T method 
(Livak & Schmittgen, 2001) and normalized to cyclophilin A. Values were compared using 
independent samples t-tests and differences were reported as significant when P < .05. SE were 
calculated using conventional error propagation methods and results are presented as fold 
differences in transcript expression between preterm and full term pigs.   
Results 
 mRNA transcript abundance for GLUT4, glycogen phosphorylase, and CPT I was 
increased (P < .05) in preterm pigs relative to term pigs.  Expression in preterm pigs was 3.58 
fold greater for GLUT4 (Figure 1), 4.68-fold greater for glycogen phosphorylase (Figure 2), and 
3.5 fold greater for CPT I (Figure 3).  Abundance of GLUT1 (Figure 1) and glycogen synthase 
(Figure 2) transcripts did not differ between treatment groups.   
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Figure 2 Glycogen phosphorylase and glycogen synthase relative transcript 
abundance in preterm (n=5) and full term (n=6) pigs.  Bars represent mean ± 
SEM.  *Different from the corresponding full term, P < .05. 
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Figure 3 Muscle CPT I  relative transcript abundance in preterm (n=5) and full 
term (n=6) pigs.  Bars represent mean  SEM.  *Different from the 
corresponding full term, P < .05. 
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Discussion 
 The observed differences support our hypothesis that preterm birth is associated with 
impairment of insulin-stimulated glucose transport in skeletal muscle. Specifically, the elevated 
GLUT4 transcription in preterm pigs appears to represent a physiological attempt to augment 
muscle tissue capacity for glucose uptake from the bloodstream.  Two different interpretations 
seem plausible to explain this association.   
As birth is known to mark the approximate beginning of the transition from GLUT1 to 
GLUT4 mediated glucose uptake, the elevated GLUT4 transcription could be perceived as part 
of a normal, but maladaptive developmental progression.  Because our preterm samples were 
taken at a time point equivalent to the 112
th
 day of gestation in full term pigs (112 days 
postconceptional age), the observed increase in GLUT4 transcription could represent an acute 
change that effectively facilitates the GLUT1-GLUT4 transition in full term neonates.  In this 
case, our results would indicate that this increase in GLUT4 transcription occurs at a specific 
postconceptional age, insensitive to variation in gestation length.  The apparent consistency of 
the developmental timing achieved by this process is one benefit that could possibly have guided 
selection for such a system. Additionally, it may be advantageous for the onset of this transition 
to occur slightly prior to birth, rather than as a reaction to parturition.  Unfortunately, this pattern 
of development would also leave preterm neonates with an immature profile of skeletal muscle 
GLUT4 expression, and would likely produce a deficiency in insulin-stimulated glucose 
disposal. 
Alternatively, if the timing of the GLUT1-GLUT4 transition is responsive to the event of 
birth itself, then the observed increase in GLUT4 transcription may instead represent a 
physiological response to dysregulation of glucose homeostasis in the preterm neonate.  In this 
case, although the mechanisms controlling metabolic development would be sensitive to the 
attenuated length of gestation, the physical immaturity of the neonate may still result in impaired 
glucose transport. This could occur due to wide variety of circumstances, but two possible 
examples would be an absence of sufficient cellular resources to increase GLUT4 expression or 
defective function of the signaling pathway that stimulates GLUT4’s response to insulin.  The 
latter is already known to be the initial metabolic defect in the development of type 2 diabetes 
(DeFronzo & Tripathy, 2009), which is a condition that is similarly characterized by peripheral 
insulin resistance and hyperglycemia.  Regardless of the specific nature of the impairment, it is 
reasonable to expect that the resulting decrease in intracellular glucose concentration would 
trigger a negative feedback loop, which would ultimately stimulate increased GLUT4 
transcription.   
Each of the above explanations appears to be plausible within the context of current 
knowledge about preterm birth and glucose homeostasis in the perinatal period. Additionally, the 
proposed processes are not mutually exclusive.  If low intracellular glucose concentrations do 
lead to increased GLUT4 transcription, this would be expected to occur regardless of the reason 
for glucose deficiency.  Accordingly, if glucose uptake is impaired in preterm neonates by a 
developmental delay in the GLUT1-GLUT4 transition, it is likely that both explanations are 
partially responsible for the observed elevation in GLUT4 transcription. More importantly, any 
of these interpretations implies that the observed difference in the quantity of GLUT4 transcripts 
indicates a high probability for impairment of insulin-stimulated glucose transport in the skeletal 
muscle of preterm pigs.   
The specific cause of this impairment is less relevant to the central hypothesis of our 
study, but interestingly, the observed similarity of GLUT1 transcript abundance in preterm and 
full term pigs does provide some insight into this question.  It suggests that the postnatal pattern 
of GLUT1 transporter expression is unaffected by variation in gestation length, thus providing 
some evidence that the natural developmental transition from GLUT1 to GLUT4 is equivalently 
active in preterm and full term pigs of the same chronological age.  This is only weak evidence 
however, as the size of our sample may not have provided adequate statistical power to detect a 
real difference in GLUT1 transcription.  Although non-significant, our results did indicate that 
GLUT1 transcripts were nearly twice as abundant in full term versus preterm pigs.  This is 
noteworthy, because this difference is in the direction that would be expected if a decrease in 
GLUT1 transcription occurs in all pigs, concomitant to the observed increase in GLUT4 
transcription, at approximately 112 days postconceptional age.  Again, our results suggest that 
both of these explanations are plausible, underscoring the need for additional research in this 
area.   
The observed elevation of CPT I and glycogen phosphorylase transcription in preterm 
pigs provides further evidence that glucose uptake is impaired in preterm skeletal muscle.  As we 
hypothesized, these results suggest that these muscle tissues must derive a greater proportion of 
energy from fatty acids and glycogen due to inadequate concentrations of intracellular glucose.  
Contrary to our hypothesis, the equivalent quantity of glycogen synthase transcripts observed 
across treatments suggests that the enzymatic capacity for glycogen synthesis is not impaired in 
neonates born preterm.   
 Collectively, the results of the current study provide compelling evidence that insulin-
stimulated glucose transport is impaired in the skeletal muscle of preterm neonates.  However, 
the cross-sectional nature of this data provides very little basis for assumptions of causality. A 
more extensive comparison of these gene transcripts, at additional time points in the perinatal 
period, could be very helpful in illuminating the true nature of the observed differences.  
Furthermore, the relationships between quantities of gene transcription, protein expression, and 
biological activity are not always easily predictable.  Before the results of this study can be 
linked to any clinically observable phenomena, corroborating evidence is needed from additional 
research employing techniques such as western blotting and enzyme activity assays.   
In spite of these limitations, our results do provide important preliminary findings that 
should inform future research in this field.  To our knowledge, this is the first investigation that 
has directly examined molecular differences relevant to glucose homeostasis in the skeletal 
muscle of preterm and full term neonates.  The elevated quantities of GLUT4, glycogen 
phosphorylase, and CPT I transcripts in our sample suggest that this is a promising new direction 
for investigations of insulin resistance and hyperglycemia in this population.  We hope that 
future research will further examine the relationship between preterm birth and insulin-
stimulated muscle glucose disposal, because a better understanding of this topic is clearly needed 
to inform development of optimal nutritional therapies and minimize the risk of hyperglycemia 
in preterm infants receiving parenteral nutrition.    
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